Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 1 day agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
A better COVID treatment for the immunocompromised? Researchers create a non-toxic potential...
Medical Xpress· 5 days agoThis has led some patients to be hospitalized with kidney failure after taking Paxlovid due to...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via Yahoo Finance· 3 days agoOn Wednesday, Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year...
High-risk patients with COVID symptoms should use PCR rather than rapid tests, study suggests
Center for Infectious Disease Research and Policy· 2 days agoStudy findings that reveal a sensitivity of 47% for COVID-19 rapid antigen tests (RATs) compared...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 2 days agoShares of Moderna rose more than 7 percent in early morning trading. Pfizer, the New York-based drug...
Study finds metformin reduces COVID-19 viral load, viral rebound
Medical Xpress· 2 days agoA team of University of Minnesota researchers found that metformin, a drug commonly used to treat...
Pfizer lifts 2024 profit view on cost cuts, higher COVID vaccine demand
WHTC 1450 Holland· 4 days ago(Reuters) -Pfizer lifted its annual profit forecast on Wednesday, banking on cost cuts and...
Pfizer lifts profit forecast as CEO sees reason for optimism in 2024
Reuters via Yahoo Finance· 4 days ago(Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
St. Joseph News-Press· 5 days ago(NYSE Amer: NNVC ) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines,...
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 4 days agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...